The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors

Objective: This study aimed to investigate the prognostic value of the gastric immune prognostic index (GIPI) in gastric cancer patients treated with programmed death 1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors.Methods: This study was conducted to elucidate the role of GIPI using the data fr...

Full description

Bibliographic Details
Main Authors: Li Chen, Ruihu Zhao, Hao Sun, Rong Huang, Hongming Pan, Yanjiao Zuo, Lele Zhang, Yingwei Xue, Xingrui Li, Hongjiang Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
gastric cancer
gastric immune prognostic index
immune checkpoint inhibitors
derived neutrophil to lymphocyte ratio
lactate dehydrogenase
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.833584/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.833584/full

Similar Items